Loading…

Precise correlation between MRI and histopathology – Exploring treatment margins for MRI-guided localized breast cancer therapy

Abstract Background Magnetic resonance imaging (MRI) is more often considered to guide, evaluate or select patients for partial breast irradiation (PBI) or minimally invasive therapy. Safe treatment margins around the MRI-visible lesion (MRI-GTV) are needed to account for surrounding subclinical occ...

Full description

Saved in:
Bibliographic Details
Published in:Radiotherapy and oncology 2010-11, Vol.97 (2), p.225-232
Main Authors: Schmitz, Annemarie C, van den Bosch, Maurice A.A.J, Loo, Claudette E, Mali, Willem P.Th.M, Bartelink, Harry, Gertenbach, Maria, Holland, Roland, Peterse, Johannes L, Rutgers, Emiel J.Th, Gilhuijs, Kenneth G
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c416t-11f8244638e21e1674d3c67a84927d0fb009f381d04f30fcd736493f44c27f503
cites cdi_FETCH-LOGICAL-c416t-11f8244638e21e1674d3c67a84927d0fb009f381d04f30fcd736493f44c27f503
container_end_page 232
container_issue 2
container_start_page 225
container_title Radiotherapy and oncology
container_volume 97
creator Schmitz, Annemarie C
van den Bosch, Maurice A.A.J
Loo, Claudette E
Mali, Willem P.Th.M
Bartelink, Harry
Gertenbach, Maria
Holland, Roland
Peterse, Johannes L
Rutgers, Emiel J.Th
Gilhuijs, Kenneth G
description Abstract Background Magnetic resonance imaging (MRI) is more often considered to guide, evaluate or select patients for partial breast irradiation (PBI) or minimally invasive therapy. Safe treatment margins around the MRI-visible lesion (MRI-GTV) are needed to account for surrounding subclinical occult disease. Purpose To precisely compare MRI findings with histopathology, and to obtain detailed knowledge about type, rate, quantity and distance of occult disease around the MRI-GTV. Methods and materials Patients undergoing MRI and breast-conserving therapy were prospectively included. The wide local excision specimens were subjected to detailed microscopic examination. The size of the invasive (index) tumor was compared with the MRI-GTV. The gross tumor volume (GTV) was defined as the pre-treatment visible lesion. Subclinical tumor foci were reconstructed at various distances to the MRI-GTV. Results Sixty-two patients (64 breasts) were included. The mean size difference between MRI-GTV and the index tumor was 1.3 mm. Subclinical disease occurred in 52% and 25% of the specimens at distances ⩾10 mm and ⩾20 mm, respectively, from the MRI-GTV. Conclusions For MRI-guided minimally invasive therapy, typical treatment margins of 10 mm around the MRI-GTV may include occult disease in 52% of patients. When surgery achieves a 10 mm tumor-free margin around the MRI-GTV, radiotherapy to the tumor bed may require clinical target volume margins >10 mm in up to one-fourth of the patients.
doi_str_mv 10.1016/j.radonc.2010.07.025
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_763175387</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0167814010004780</els_id><sourcerecordid>763175387</sourcerecordid><originalsourceid>FETCH-LOGICAL-c416t-11f8244638e21e1674d3c67a84927d0fb009f381d04f30fcd736493f44c27f503</originalsourceid><addsrcrecordid>eNqFkU2OEzEQhVsIxISBGyDkHasO5Z-0nQ0SGg0w0iAQP2vLsasTh47d2G4grOAM3JCT4FYGFmxYuWS9V6X3vaZ5SGFJgXZP9stkXAx2yaB-gVwCW91qFlTJdQtKydvNospkq6iAs-ZeznsAYMDl3eaMgWIdsG7R_HiT0PqMxMaUcDDFx0A2WL4gBvLq7RUxwZGdzyWOpuziELdH8uv7T3L5dRxi8mFLSkJTDhgKOZi09SGTPqbZ2m4n79CRIVoz-G912lRpLsSaYDGRssNkxuP95k5vhowPbt7z5sPzy_cXL9vr1y-uLp5dt1bQrrSU9ooJ0XGFjGINJhy3nTRKrJl00G8A1j1X1IHoOfTWSd6JNe-FsEz2K-DnzePT3jHFTxPmog8-WxwGEzBOWcuOU7niSlalOCltijkn7PWYfA131BT0zF7v9Ym9ntlrkLqyr7ZHNwemzQHdX9Mf2FXw9CTAGvOzx6Sz9VhZOF9LKNpF_78L_y6wgw--4v2IR8z7OKVQEWqqM9Og3839z_XT2ryQCvhv5sityw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>763175387</pqid></control><display><type>article</type><title>Precise correlation between MRI and histopathology – Exploring treatment margins for MRI-guided localized breast cancer therapy</title><source>ScienceDirect Journals</source><creator>Schmitz, Annemarie C ; van den Bosch, Maurice A.A.J ; Loo, Claudette E ; Mali, Willem P.Th.M ; Bartelink, Harry ; Gertenbach, Maria ; Holland, Roland ; Peterse, Johannes L ; Rutgers, Emiel J.Th ; Gilhuijs, Kenneth G</creator><creatorcontrib>Schmitz, Annemarie C ; van den Bosch, Maurice A.A.J ; Loo, Claudette E ; Mali, Willem P.Th.M ; Bartelink, Harry ; Gertenbach, Maria ; Holland, Roland ; Peterse, Johannes L ; Rutgers, Emiel J.Th ; Gilhuijs, Kenneth G</creatorcontrib><description>Abstract Background Magnetic resonance imaging (MRI) is more often considered to guide, evaluate or select patients for partial breast irradiation (PBI) or minimally invasive therapy. Safe treatment margins around the MRI-visible lesion (MRI-GTV) are needed to account for surrounding subclinical occult disease. Purpose To precisely compare MRI findings with histopathology, and to obtain detailed knowledge about type, rate, quantity and distance of occult disease around the MRI-GTV. Methods and materials Patients undergoing MRI and breast-conserving therapy were prospectively included. The wide local excision specimens were subjected to detailed microscopic examination. The size of the invasive (index) tumor was compared with the MRI-GTV. The gross tumor volume (GTV) was defined as the pre-treatment visible lesion. Subclinical tumor foci were reconstructed at various distances to the MRI-GTV. Results Sixty-two patients (64 breasts) were included. The mean size difference between MRI-GTV and the index tumor was 1.3 mm. Subclinical disease occurred in 52% and 25% of the specimens at distances ⩾10 mm and ⩾20 mm, respectively, from the MRI-GTV. Conclusions For MRI-guided minimally invasive therapy, typical treatment margins of 10 mm around the MRI-GTV may include occult disease in 52% of patients. When surgery achieves a 10 mm tumor-free margin around the MRI-GTV, radiotherapy to the tumor bed may require clinical target volume margins &gt;10 mm in up to one-fourth of the patients.</description><identifier>ISSN: 0167-8140</identifier><identifier>EISSN: 1879-0887</identifier><identifier>DOI: 10.1016/j.radonc.2010.07.025</identifier><identifier>PMID: 20826026</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>Adult ; Aged ; Breast Neoplasms - pathology ; Breast Neoplasms - radiotherapy ; Clinical target volume ; Female ; Hematology, Oncology and Palliative Medicine ; Humans ; Localized breast cancer therapy ; Magnetic Resonance Imaging ; Middle Aged ; Minimally invasive therapy ; MRI ; Partial breast irradiation ; Radiotherapy Planning, Computer-Assisted ; Treatment margins ; Tumor Burden</subject><ispartof>Radiotherapy and oncology, 2010-11, Vol.97 (2), p.225-232</ispartof><rights>Elsevier Ireland Ltd</rights><rights>2010 Elsevier Ireland Ltd</rights><rights>Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c416t-11f8244638e21e1674d3c67a84927d0fb009f381d04f30fcd736493f44c27f503</citedby><cites>FETCH-LOGICAL-c416t-11f8244638e21e1674d3c67a84927d0fb009f381d04f30fcd736493f44c27f503</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20826026$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schmitz, Annemarie C</creatorcontrib><creatorcontrib>van den Bosch, Maurice A.A.J</creatorcontrib><creatorcontrib>Loo, Claudette E</creatorcontrib><creatorcontrib>Mali, Willem P.Th.M</creatorcontrib><creatorcontrib>Bartelink, Harry</creatorcontrib><creatorcontrib>Gertenbach, Maria</creatorcontrib><creatorcontrib>Holland, Roland</creatorcontrib><creatorcontrib>Peterse, Johannes L</creatorcontrib><creatorcontrib>Rutgers, Emiel J.Th</creatorcontrib><creatorcontrib>Gilhuijs, Kenneth G</creatorcontrib><title>Precise correlation between MRI and histopathology – Exploring treatment margins for MRI-guided localized breast cancer therapy</title><title>Radiotherapy and oncology</title><addtitle>Radiother Oncol</addtitle><description>Abstract Background Magnetic resonance imaging (MRI) is more often considered to guide, evaluate or select patients for partial breast irradiation (PBI) or minimally invasive therapy. Safe treatment margins around the MRI-visible lesion (MRI-GTV) are needed to account for surrounding subclinical occult disease. Purpose To precisely compare MRI findings with histopathology, and to obtain detailed knowledge about type, rate, quantity and distance of occult disease around the MRI-GTV. Methods and materials Patients undergoing MRI and breast-conserving therapy were prospectively included. The wide local excision specimens were subjected to detailed microscopic examination. The size of the invasive (index) tumor was compared with the MRI-GTV. The gross tumor volume (GTV) was defined as the pre-treatment visible lesion. Subclinical tumor foci were reconstructed at various distances to the MRI-GTV. Results Sixty-two patients (64 breasts) were included. The mean size difference between MRI-GTV and the index tumor was 1.3 mm. Subclinical disease occurred in 52% and 25% of the specimens at distances ⩾10 mm and ⩾20 mm, respectively, from the MRI-GTV. Conclusions For MRI-guided minimally invasive therapy, typical treatment margins of 10 mm around the MRI-GTV may include occult disease in 52% of patients. When surgery achieves a 10 mm tumor-free margin around the MRI-GTV, radiotherapy to the tumor bed may require clinical target volume margins &gt;10 mm in up to one-fourth of the patients.</description><subject>Adult</subject><subject>Aged</subject><subject>Breast Neoplasms - pathology</subject><subject>Breast Neoplasms - radiotherapy</subject><subject>Clinical target volume</subject><subject>Female</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Localized breast cancer therapy</subject><subject>Magnetic Resonance Imaging</subject><subject>Middle Aged</subject><subject>Minimally invasive therapy</subject><subject>MRI</subject><subject>Partial breast irradiation</subject><subject>Radiotherapy Planning, Computer-Assisted</subject><subject>Treatment margins</subject><subject>Tumor Burden</subject><issn>0167-8140</issn><issn>1879-0887</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqFkU2OEzEQhVsIxISBGyDkHasO5Z-0nQ0SGg0w0iAQP2vLsasTh47d2G4grOAM3JCT4FYGFmxYuWS9V6X3vaZ5SGFJgXZP9stkXAx2yaB-gVwCW91qFlTJdQtKydvNospkq6iAs-ZeznsAYMDl3eaMgWIdsG7R_HiT0PqMxMaUcDDFx0A2WL4gBvLq7RUxwZGdzyWOpuziELdH8uv7T3L5dRxi8mFLSkJTDhgKOZi09SGTPqbZ2m4n79CRIVoz-G912lRpLsSaYDGRssNkxuP95k5vhowPbt7z5sPzy_cXL9vr1y-uLp5dt1bQrrSU9ooJ0XGFjGINJhy3nTRKrJl00G8A1j1X1IHoOfTWSd6JNe-FsEz2K-DnzePT3jHFTxPmog8-WxwGEzBOWcuOU7niSlalOCltijkn7PWYfA131BT0zF7v9Ym9ntlrkLqyr7ZHNwemzQHdX9Mf2FXw9CTAGvOzx6Sz9VhZOF9LKNpF_78L_y6wgw--4v2IR8z7OKVQEWqqM9Og3839z_XT2ryQCvhv5sityw</recordid><startdate>20101101</startdate><enddate>20101101</enddate><creator>Schmitz, Annemarie C</creator><creator>van den Bosch, Maurice A.A.J</creator><creator>Loo, Claudette E</creator><creator>Mali, Willem P.Th.M</creator><creator>Bartelink, Harry</creator><creator>Gertenbach, Maria</creator><creator>Holland, Roland</creator><creator>Peterse, Johannes L</creator><creator>Rutgers, Emiel J.Th</creator><creator>Gilhuijs, Kenneth G</creator><general>Elsevier Ireland Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20101101</creationdate><title>Precise correlation between MRI and histopathology – Exploring treatment margins for MRI-guided localized breast cancer therapy</title><author>Schmitz, Annemarie C ; van den Bosch, Maurice A.A.J ; Loo, Claudette E ; Mali, Willem P.Th.M ; Bartelink, Harry ; Gertenbach, Maria ; Holland, Roland ; Peterse, Johannes L ; Rutgers, Emiel J.Th ; Gilhuijs, Kenneth G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c416t-11f8244638e21e1674d3c67a84927d0fb009f381d04f30fcd736493f44c27f503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Breast Neoplasms - pathology</topic><topic>Breast Neoplasms - radiotherapy</topic><topic>Clinical target volume</topic><topic>Female</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Localized breast cancer therapy</topic><topic>Magnetic Resonance Imaging</topic><topic>Middle Aged</topic><topic>Minimally invasive therapy</topic><topic>MRI</topic><topic>Partial breast irradiation</topic><topic>Radiotherapy Planning, Computer-Assisted</topic><topic>Treatment margins</topic><topic>Tumor Burden</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schmitz, Annemarie C</creatorcontrib><creatorcontrib>van den Bosch, Maurice A.A.J</creatorcontrib><creatorcontrib>Loo, Claudette E</creatorcontrib><creatorcontrib>Mali, Willem P.Th.M</creatorcontrib><creatorcontrib>Bartelink, Harry</creatorcontrib><creatorcontrib>Gertenbach, Maria</creatorcontrib><creatorcontrib>Holland, Roland</creatorcontrib><creatorcontrib>Peterse, Johannes L</creatorcontrib><creatorcontrib>Rutgers, Emiel J.Th</creatorcontrib><creatorcontrib>Gilhuijs, Kenneth G</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Radiotherapy and oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schmitz, Annemarie C</au><au>van den Bosch, Maurice A.A.J</au><au>Loo, Claudette E</au><au>Mali, Willem P.Th.M</au><au>Bartelink, Harry</au><au>Gertenbach, Maria</au><au>Holland, Roland</au><au>Peterse, Johannes L</au><au>Rutgers, Emiel J.Th</au><au>Gilhuijs, Kenneth G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Precise correlation between MRI and histopathology – Exploring treatment margins for MRI-guided localized breast cancer therapy</atitle><jtitle>Radiotherapy and oncology</jtitle><addtitle>Radiother Oncol</addtitle><date>2010-11-01</date><risdate>2010</risdate><volume>97</volume><issue>2</issue><spage>225</spage><epage>232</epage><pages>225-232</pages><issn>0167-8140</issn><eissn>1879-0887</eissn><abstract>Abstract Background Magnetic resonance imaging (MRI) is more often considered to guide, evaluate or select patients for partial breast irradiation (PBI) or minimally invasive therapy. Safe treatment margins around the MRI-visible lesion (MRI-GTV) are needed to account for surrounding subclinical occult disease. Purpose To precisely compare MRI findings with histopathology, and to obtain detailed knowledge about type, rate, quantity and distance of occult disease around the MRI-GTV. Methods and materials Patients undergoing MRI and breast-conserving therapy were prospectively included. The wide local excision specimens were subjected to detailed microscopic examination. The size of the invasive (index) tumor was compared with the MRI-GTV. The gross tumor volume (GTV) was defined as the pre-treatment visible lesion. Subclinical tumor foci were reconstructed at various distances to the MRI-GTV. Results Sixty-two patients (64 breasts) were included. The mean size difference between MRI-GTV and the index tumor was 1.3 mm. Subclinical disease occurred in 52% and 25% of the specimens at distances ⩾10 mm and ⩾20 mm, respectively, from the MRI-GTV. Conclusions For MRI-guided minimally invasive therapy, typical treatment margins of 10 mm around the MRI-GTV may include occult disease in 52% of patients. When surgery achieves a 10 mm tumor-free margin around the MRI-GTV, radiotherapy to the tumor bed may require clinical target volume margins &gt;10 mm in up to one-fourth of the patients.</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>20826026</pmid><doi>10.1016/j.radonc.2010.07.025</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0167-8140
ispartof Radiotherapy and oncology, 2010-11, Vol.97 (2), p.225-232
issn 0167-8140
1879-0887
language eng
recordid cdi_proquest_miscellaneous_763175387
source ScienceDirect Journals
subjects Adult
Aged
Breast Neoplasms - pathology
Breast Neoplasms - radiotherapy
Clinical target volume
Female
Hematology, Oncology and Palliative Medicine
Humans
Localized breast cancer therapy
Magnetic Resonance Imaging
Middle Aged
Minimally invasive therapy
MRI
Partial breast irradiation
Radiotherapy Planning, Computer-Assisted
Treatment margins
Tumor Burden
title Precise correlation between MRI and histopathology – Exploring treatment margins for MRI-guided localized breast cancer therapy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T22%3A05%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Precise%20correlation%20between%20MRI%20and%20histopathology%20%E2%80%93%20Exploring%20treatment%20margins%20for%20MRI-guided%20localized%20breast%20cancer%20therapy&rft.jtitle=Radiotherapy%20and%20oncology&rft.au=Schmitz,%20Annemarie%20C&rft.date=2010-11-01&rft.volume=97&rft.issue=2&rft.spage=225&rft.epage=232&rft.pages=225-232&rft.issn=0167-8140&rft.eissn=1879-0887&rft_id=info:doi/10.1016/j.radonc.2010.07.025&rft_dat=%3Cproquest_cross%3E763175387%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c416t-11f8244638e21e1674d3c67a84927d0fb009f381d04f30fcd736493f44c27f503%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=763175387&rft_id=info:pmid/20826026&rfr_iscdi=true